Follow The Filings

MIRA MIRA Pharmaceuticals

MIRA Pharmaceuticals earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.07,9.01
8-K 7.01,9.01
10-Q
8-K 7.01,9.01
8-K 3.01
DEF 14A
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.02,9.01
8-K 1.01,7.01,9.01
8-K 1.01,7.01,9.01
10-Q
8-K 8.01
8-K 7.01
10-K
8-K 8.01
8-K 8.01
8-K 8.01
8-K 5.02
424B5
8-K 8.01,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Jun 12, 2026 (4 forms)
4 Period Mar 30, 2026

3 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.